The MEK/ERK pathway is also involved in mediating EGF-stimulated serine biosynthesis in colorectal cancer cells by stabilising interleukin enhancer binding factor 3 (ILF3) (K. Li et al., 2020a). The gene discussed is ILF3; the disease is colorectal cancer.